Skip to main content
. 2021 Feb 21;46(9):1643–1649. doi: 10.1038/s41386-021-00984-w

Fig. 3. Change in PTSD and MD symptoms based on initial PTSD severity before treatment.

Fig. 3

A Change in PTSD symptoms during the treatment period depending on the initial level of PTSD (mean PCL-S score), B change in MD symptoms during the treatment period depending on the initial level of PTSD (mean PCL-S score). Propranolol = “traumatic memory reactivation + propranolol” group; Placebo = “traumatic memory reactivation + placebo” group. *p < 0.05, **p < 0.01.